Cargando…
Improved pathology reporting in NAFLD/NASH for clinical trials
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788244/ https://www.ncbi.nlm.nih.gov/pubmed/34753791 http://dx.doi.org/10.1136/jclinpath-2021-207967 |
| _version_ | 1784639518265049088 |
|---|---|
| author | Langford, Caitlin Rose Goldinger, Marc H Treanor, Darren McGenity, Clare Dillman, Jonathan R Allende, Daniela S Goldin, Robert Brunt, Elizabeth M Zatloukal, Kurt Denk, Helmut Fleming, Kenneth A |
| author_facet | Langford, Caitlin Rose Goldinger, Marc H Treanor, Darren McGenity, Clare Dillman, Jonathan R Allende, Daniela S Goldin, Robert Brunt, Elizabeth M Zatloukal, Kurt Denk, Helmut Fleming, Kenneth A |
| author_sort | Langford, Caitlin Rose |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8788244 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87882442022-02-07 Improved pathology reporting in NAFLD/NASH for clinical trials Langford, Caitlin Rose Goldinger, Marc H Treanor, Darren McGenity, Clare Dillman, Jonathan R Allende, Daniela S Goldin, Robert Brunt, Elizabeth M Zatloukal, Kurt Denk, Helmut Fleming, Kenneth A J Clin Pathol Viewpoint BMJ Publishing Group 2022-02 2021-11-09 /pmc/articles/PMC8788244/ /pubmed/34753791 http://dx.doi.org/10.1136/jclinpath-2021-207967 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Viewpoint Langford, Caitlin Rose Goldinger, Marc H Treanor, Darren McGenity, Clare Dillman, Jonathan R Allende, Daniela S Goldin, Robert Brunt, Elizabeth M Zatloukal, Kurt Denk, Helmut Fleming, Kenneth A Improved pathology reporting in NAFLD/NASH for clinical trials |
| title | Improved pathology reporting in NAFLD/NASH for clinical trials |
| title_full | Improved pathology reporting in NAFLD/NASH for clinical trials |
| title_fullStr | Improved pathology reporting in NAFLD/NASH for clinical trials |
| title_full_unstemmed | Improved pathology reporting in NAFLD/NASH for clinical trials |
| title_short | Improved pathology reporting in NAFLD/NASH for clinical trials |
| title_sort | improved pathology reporting in nafld/nash for clinical trials |
| topic | Viewpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788244/ https://www.ncbi.nlm.nih.gov/pubmed/34753791 http://dx.doi.org/10.1136/jclinpath-2021-207967 |
| work_keys_str_mv | AT langfordcaitlinrose improvedpathologyreportinginnafldnashforclinicaltrials AT goldingermarch improvedpathologyreportinginnafldnashforclinicaltrials AT treanordarren improvedpathologyreportinginnafldnashforclinicaltrials AT mcgenityclare improvedpathologyreportinginnafldnashforclinicaltrials AT dillmanjonathanr improvedpathologyreportinginnafldnashforclinicaltrials AT allendedanielas improvedpathologyreportinginnafldnashforclinicaltrials AT goldinrobert improvedpathologyreportinginnafldnashforclinicaltrials AT bruntelizabethm improvedpathologyreportinginnafldnashforclinicaltrials AT zatloukalkurt improvedpathologyreportinginnafldnashforclinicaltrials AT denkhelmut improvedpathologyreportinginnafldnashforclinicaltrials AT flemingkennetha improvedpathologyreportinginnafldnashforclinicaltrials |